European Journal of Nutrition

, Volume 45, Issue 4, pp 196–204

1,25–Dihydroxyvitamin D and 25–hydroxyvitamin D—mediated regulation of TRPV6 (a putative epithelial calcium channel) mRNA expression in Caco–2 cells

  • S. Taparia
  • J. C. Fleet
  • J.–B. Peng
  • X. D. Wang
  • R. J. Wood
ORIGINAL CONTRIBUTION

Summary

Background

TRPV6 is a member of the vanilloid subfamily of transient receptor potential (TRP) proteins and likely functions as an epithelial calcium channel in calcium–transporting organs, such as the intestine, kidney, and placenta. TRPV6 mRNA expression is strongly regulated by 1,25–dihydroxyvitamin D (1,25VD), the active hormonal form of vitamin D, in intestine and in Caco–2 cells, a human colon cancer cell line.

Aim of the study

The aim of the present study was to characterise the mode of regulation of the 1,25VD–mediated TRPV6 mRNA expression and to test the effect of the precursor of 1,25VD namely 25 hydroxyvitamin D (25 VD) on TRPV6 mRNA expression in Caco–2 cells.

Methods

Caco–2 cells were treated in a 2 x 2 format with 1,25VD and the transcriptional inhibitor actinomycin D (AD, 4μg/ml), and also with translational inhibitor cycloheximide (CHX, 10 μg/ml) after 14 days in culture and TRPV6 mRNA levels were determined using reverse transcription–real time PCR.TRPV6 mRNA half life studies were performed by inhibiting transcription followed by sampling at various time points for TRPV6 mRNA. Varying concentrations of 25 VD were used to test their effect on TRPV6 mRNA in the presence of 5% FBS and also in the absence of serum (but containing insulin–transferrin–selenium mixture) for 24 h.

Results

Treatment with 10–7 M 1,25VD for 8 h resulted in a 60–fold increase in TRPV6 mRNA and this increase could be completely blocked with AD. Treatment with CHX to inhibit de novo protein synthesis did not prevent the initiation of 1,25VD–induced TRPV6 expression, although it did reduce the extent of TRPV6 mRNA accumulation. We found that TRPV6 mRNA half–life was 8 h in Caco–2 cells and was not altered by 1,25VD treatment. Finally, we observed that treatment with 10–6 M of the pro–hormone 25 VD for 24 h resulted in a significant increase in TRPV6 expression in Caco–2 cells, which is consistent with the presence of 1α–hydroxylase (CYP27B1) expression in Caco–2 cells and a possible autocrine vitamin D signaling pathway in colon cells.

Conclusions

1,25 dihydroxyvitamin D regulates TRPV6 expression by a process that requires new mRNA and protein synthesis and the point of regulation lies likely at the transcriptional level especially since vitamin D did not increase the half life of TRPV6 mRNA. In addition, the prohormone form of 1,25 dihydroxyvitamin D, i. e. the 25 hydroxyvitamin D, induced TRPV6 mRNA expression in Caco–2 cells.

Key words

CaT1 TRPV6 gene expression vitamin D intestine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Norman AW (1990) Intestinal calcium absorption: a vitamin D–hormone–mediated adaptive response. Am J Clin Nutr 51:290–300Google Scholar
  2. 2.
    Bronner F (1991) Calcium transport across epithelia. Int Rev Cytol 131:169–212CrossRefGoogle Scholar
  3. 3.
    Clapham DE (2003) TRP channels as cellular sensors. Nature 426:517–524CrossRefGoogle Scholar
  4. 4.
    Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA (1999) Molecular cloning and characterization of a channel–like transporter mediating intestinal calcium absorption. J Biol Chem 274:22739–22746CrossRefGoogle Scholar
  5. 5.
    Peng JB, Chen XZ, Berger UV, Weremowicz S, Morton CC, Vassilev PM, Brown EM, Hediger MA (2000) Human calcium transport protein CaT1. Biochem Biophys Res Commun 278:326–332CrossRefGoogle Scholar
  6. 6.
    Wood RJ, Tchack L, Taparia S (2001) 1, 25–Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco–2 human intestinal cell line. BMC Physiol 1:11CrossRefGoogle Scholar
  7. 7.
    Giuliano AR, Wood RJ (1991) Vitamin D–regulated calcium transport in Caco– 2 cells: unique in vitro model. Am J Physiol 260:G207–G212Google Scholar
  8. 8.
    Fleet JC, Wood RJ (1999) Specific 1, 25(OH)2D3–mediated regulation of transcellular calcium transport in Caco–2 cells. Am J Physiol 276:G958–G964Google Scholar
  9. 9.
    Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S (2003) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1, 25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144:3885–3894CrossRefGoogle Scholar
  10. 10.
    Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, Bindels RJ, Collen D, Carmeliet P, Bouillon R, Carmeliet G (2001) Duodenal calcium absorption in vitamin D receptor–knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA 98:13324–13329CrossRefGoogle Scholar
  11. 11.
    Jones G, Strugnell SA, DeLuca HF (1998) Current understanding of the molecular actions of vitamin D Physiol Rev 78:1193–1231Google Scholar
  12. 12.
    Gonzalez EA, Disthabanchong S, Kowalewski R, Martin KJ (2002) Mechanisms of the regulation of EGF receptor gene expression by calcitriol and parathyroid hormone in UMR 106–01 cells. Kidney Int 61:1627–1634CrossRefGoogle Scholar
  13. 13.
    Yanaka N, Akatsuka H, Kawai E, Omori K (1998) 1, 25–Dihydroxyvitamin D3 upregulates natriuretic peptide receptor– C expression in mouse osteoblasts. Am J Physiol 275:E965–E973Google Scholar
  14. 14.
    Mosavin R, Mellon WS (1996) Posttranscriptional regulation of osteocalcin mRNA in clonal osteoblast cells by 1, 25– dihydroxyvitamin D3. Arch Biochem Biophys 332:142–152CrossRefGoogle Scholar
  15. 15.
    Grumbles RM, Shao L, Jeffrey JJ, Howell DS (1996) Regulation of rat interstitial collagenase gene expression in growth cartilage and chondrocytes by vitamin D3, interleukin–1 beta, and okadaic acid. J Cell Biochem 63:395–409CrossRefGoogle Scholar
  16. 16.
    Biskobing DM, Fan D, Rubin J (1997) cfms mRNA is regulated posttranscriptionally by 1, 25(OH)2D3 in HL–60 cells. Calcif Tissue Int 61:205–209CrossRefGoogle Scholar
  17. 17.
    Tobler A, Miller CW, Norman AW, Koeffler HP (1988) 1, 25–Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte–macrophage colony–stimulating factor) posttranscriptionally. J Clin Invest 81:1819–1823CrossRefGoogle Scholar
  18. 18.
    Mangasarian K, Mellon WS (1993) 1, 25– Dihydroxyvitamin D–3 destabilizes c–myc mRNA in HL–60 leukemic cells. Biochim Biophys Acta 1172:55–63Google Scholar
  19. 19.
    Lou YR, Laaksi I, Syvala H, Blauer M, Tammela TL, Ylikomi T, Tuohimaa P (2004) 25–hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. Faseb J 18:332–334Google Scholar
  20. 20.
    Kallay E, Bareis P, Bajna E, Kriwanek S, Bonner E, Toyokuni S, Cross HS (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem Toxicol 40:1191–1196CrossRefGoogle Scholar
  21. 21.
    Schwartz GG, Eads D, Rao A, Cramer SD, Willingham MC, Chen TC, Jamieson DP, Wang L, Burnstein KL, Holick, MF, Koumenis C (2004) Pancreatic cancer cells express 25–Hydroxyvitamin D–1– hydroxylase and their proliferation is inhibited by the prohormone 25–hydroxyvitamin D3. Carcinogenesis 25:1015–1026CrossRefGoogle Scholar
  22. 22.
    Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, Hewison M (2002) The ontogeny of 25–hydroxyvitamin D(3) 1alpha–hydroxylase expression in human placenta and decidua. Am J Pathol 161:105–114Google Scholar
  23. 23.
    Segersten U, Correa P, Hewison M, Hellman P, Dralle H, Carling T, Akerstrom G, Westin G (2002) 25–hydroxyvitamin D(3)–1alpha–hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 87:2967–2972CrossRefGoogle Scholar
  24. 24.
    Friedrich M, Villena–Heinsen C, Axt– Fliedner R, Meyberg R, Tilgen W, Schmidt W, Reichrath J (2002) Analysis of 25–hydroxyvitamin D3–1alpha–hydroxylase in cervical tissue. Anticancer Res 22:183–186Google Scholar
  25. 25.
    Giuliano AR, Franceschi RT, Wood RJ (1991) Characterization of the vitamin D receptor from the Caco–2 human colon carcinoma cell line: effect of cellular differentiation. Arch Biochem Biophys 285:261–269CrossRefGoogle Scholar
  26. 26.
    Shao A, Wood RJ, Fleet JC (2001) Increased vitamin D receptor level enhances 1, 25–dihydroxyvitamin D3–mediated gene expression and calcium transport in Caco–2 cells. J Bone Miner Res 16:615–624CrossRefGoogle Scholar
  27. 27.
    Bareis P, Kallay E, Bischof MG, Bises G, Hofer H, Potzi C, Manhardt T, Bland R, Cross HS (2002) Clonal differences in expression of 25–hydroxyvitamin D(3)– 1alpha–hydroxylase, of 25–hydroxyvitamin D(3)–24–hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha, 25–dihydroxyvitamin D(3). Exp Cell Res 276:320–327CrossRefGoogle Scholar
  28. 28.
    Cross HS, Peterlik M, Reddy GS, Schuster I (1997) Vitamin D metabolism in human colon adenocarcinoma–derived Caco–2 cells: expression of 25–hydroxyvitamin D3–1alpha–hydroxylase activity and regulation of side–chain metabolism. J Steroid Biochem Mol Biol 62:21–28CrossRefGoogle Scholar
  29. 29.
    Fleet JC, Eksir F, Hance KW, Wood RJ (2002) Vitamin D–inducible calcium transport and gene expression in three Caco–2 cell lines. Am J Physiol Gastrointest Liver Physiol 283:G618–G625Google Scholar
  30. 30.
    Peng JB, Brown EM, Hediger MA (2001) Structural conservation of the genes encoding CaT1, CaT2, and related cation channels. Genomics 76:99–109CrossRefGoogle Scholar
  31. 31.
    Wang TT, Tavera–Mendoza LE, Laperriere D, Libby E, Macleod NB, Nagai Y, Bourdeau V, Konstorum A, Lallement B, Zhang R, Mader S, White JH (2005) Large–scale in silico and microarraybased identification of direct 1, 25–dihydroxyvitamin D3 target genes. Mol Endocrinol (Epub ahead of print)Google Scholar
  32. 32.
    Heaney RP, Barger–Lux MJ, Dowell MS, Chen TC, Holick MF (1997) Calcium absorptive effects of vitamin D and its major metabolites. J Clin Endocrinol Metab 82:4111–4116CrossRefGoogle Scholar
  33. 33.
    Kratz A, Ferraro M, Sluss PM, Lewandrowski KB (2004) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N Engl J Med 351(15):1548–1563CrossRefGoogle Scholar
  34. 34.
    Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 79:362–371Google Scholar
  35. 35.
    Lamprecht SA, Lipkin M (2004) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3:601–614CrossRefGoogle Scholar
  36. 36.
    Cross HS, Kallay E, Farhan H, Weiland T, Manhardt T (2003) Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Recent Results Cancer Res 164:413–425Google Scholar
  37. 37.
    Keenan MJ, Holmes RP (1991) The uptake and metabolism of 25–hydroxyvitamin D3 and vitamin D binding protein by cultured porcine kidney cells (LLCPK1). Int J Biochem 23:1225–1230CrossRefGoogle Scholar

Copyright information

© Steinkopff-Verlag 2005

Authors and Affiliations

  • S. Taparia
    • 1
    • 2
  • J. C. Fleet
    • 3
  • J.–B. Peng
    • 4
  • X. D. Wang
    • 5
  • R. J. Wood
    • 1
  1. 1.Mineral Bioavailability Laboratory, Jean Mayer USDA Human Nutrition, Research Center on AgingTufts UniversityBoston (MA) 02111USA
  2. 2.Institute of Biosciences and TechnologyTexas A&M University Health Science CenterHouston (TX)USA
  3. 3.Dept. Foods and NutritionPurdue UniversityWest Lafayette (IN)USA
  4. 4.Dept. of Medicine, Division of NephrologyUniversity of Alabama at BirminghamBirmingham (AL)USA
  5. 5.Nutrition and Cancer Biology Laboratory, Jean Mayer USDA Human Nutrition, Research Center on AgingTufts UniversityBoston (MA)USA

Personalised recommendations